Johnson & Johnson’s single-dose vaccine was used very little during the first weekend after surgery. The General Directorate of Health has raised logistics issues.
Although Health Minister Olivier Veran “relied heavily” on Janssen’s vaccine to “boost the campaign,” it got off to a shy start this weekend. As Politico noted, on April 24 and 25, very few doses of Johnson & Johnson’s new vaccine were indeed administered.
According to Public Health France, only 1,880 people received a dose of Janssen on Saturday and 124 people on Sunday. According to the General Directorate of Health (DGS) polled by BFMTV.com, this is simply a logistics problem, not public distrust of this new vaccine, which, like AstraZeneca, poses a risk of “very rare” blood clots.
“Janssen vaccine shipments to pharmacies began on Friday 23rd and continued over the next weekend,” explains DGS. “Appointments can be made the day after the estimated delivery date of vaccines to pharmacies, that is, no earlier than Saturday 24, for specialists who eat in the very first delivered pharmacies.”
Painstaking start for all other vaccines …
The DGS also points out that the problem was the same with other vaccines at the start. The Public Health France data does show that the start is still relatively slow:
- In the first eight days of Pfizer’s operation, from December 27, 2020 to January 4, 2021, a total of 2,057 doses were administered.
- in the first four days of Moderna, from 14 to 17 January 2021, a total of 546 doses were administered.
- in the first two days of using AstraZeneca, on February 6 and 7, 2021, only 1600 doses were administered.
200,000 doses of Janssen delivered this weekend
However, these endeavors are not entirely comparable as the stocks were relatively different. More than 206,400 doses of Janssen were delivered to France this weekend. This is four times more than Pfizer (48,750 doses delivered as of December 27, 2020) and Moderna (51,600 doses delivered in January 2021) when they started. On the other hand, this is slightly less than AstraZeneca (273,600 doses delivered on February 7, 2021).
Another difference: when these vaccines were launched, vaccinations were limited to fewer people. The vaccine is now available to anyone 55 and older, a much larger audience than in December, January or February.